http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2020523311-A

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-407
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D477-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-403
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4412
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D477-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-407
filingDate 2018-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2020-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2020523311-A
titleOfInvention Carbapenem compounds and compositions for the treatment of bacterial infections
abstract The present invention provides carbapenem compounds and pharmaceutical compositions useful in the treatment of bacterial infections, such as drug resistant or multidrug resistant bacterial infections, and methods of treating such infections using such compounds and/or compositions. To do. The present invention involves administering to a host in need of such treatment an effective amount of a carbapenem compound or a and/or prodrug thereof.
priorityDate 2017-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9217480-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011125966-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010050468-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H02300187-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012147773-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03040146-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008502733-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013528659-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S63303981-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H03120280-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S62155279-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450094403
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID142494040
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467099237
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466829371
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164158183
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID146619634
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413873263
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467950214
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163470448
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465253387
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467950250
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420657405
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467099146
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420183680
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2899
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID142493991
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467171497
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466102633
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415014785
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466098155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465027494
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID142494052
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466024575
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID189460

Total number of triples: 53.